This study reveals Pyk2/Gsk3β axis activation by mitochondrial translation inhibition suppresses cholesterol gene expression via Srebp2 degradation, offering a novel approach to leukoencephalopathy. Here, SREBF2 is linked to Leukoencephalopathy.